To date, the use and translation of nanomedicine from the laboratory to the clinic has been relatively slow. Among other issues, one of the reasons for this tardiness is the lack of the availability of quick and reliable toxicity tools for the screening of nanomaterials (NMs). In this investigation, we apply a flow cytometry-based method for the detection of nanomaterialinduced oxidative stress by measurement of reactive oxygen species production in specific leukocyte subpopulations in human whole blood. The screening of a panel of relevant nanomedical-associated materials (liposomes, silica, iron oxide and functionalized single-walled carbon nanotubes) demonstrated that only the carbon nanotubes induced oxidative stress in human circulating leukocytes. In summary, we apply and corroborate a flow cytometry-based method for the simple and effective measurement of NM-induced oxidative stress in human blood subpopulations after realistic and relevant exposure scenarios which is extremely useful in future toxicological applications.The rapid development of nanotechnology goes hand in hand with concerns about the potential adverse effects of nanomaterial (NM) exposure on human health and the environment. In addition, the apparent knowledge gaps in our understanding of the interaction between NMs and cells, their transformation and their eventual fate in different biological systems mean that hazard assessment is very challenging.Nanomedicine is defined as the application and utilization of nanotechnology to medicine and human health, in particular with regard to the diagnosis and treatment of disease. Over the last two decades, a wide range of NMs with varying size, shape, charge and other physicochemical characteristics are tailored to determine specific function, resulting in desirable optical, electronic, magnetic and biological attributes. The current nanomedicine applications mainly include vehicles for targeted drug delivery, NM platforms for biomedical imaging and therapeutic applications for treating clinical diseases [1,2]. Despite these promising medical applications, the safety concern for NMs is a key determinant factor in the assessment of their clinical potential. Therefore, it is imperative to implement risk reduction strategies for all materials proposed for medical applications. The same physicochemical characteristics that make NMs desirable for medical applications might contribute to their potential adverse effects -particle size and surface properties can largely influence the bioavailability, transport, biotransformation, cellular uptake and toxicity of the material in question [3,4].Iron oxide nanoparticles (NPs) can exhibit a unique form of superparamagnetism which is highly useful and desirable in biomedicine for several medical applications, principally relating to imaging and drug delivery to the central nervous system and various tumours [5,6]. This property is believed to be size-dependent and only occurs at around 10-20 nm [7]. Iron oxide is one of the few NMs with current clin...